{"gao_id": "GAO-21-107", "published": "2020-12-14T12:00:00Z", "released": "2020-12-14T07:00:00Z", "summary": "The 340B Drug Pricing Program allows certain types of hospitals, clinics, and other entities to get discounts on prescription drugs to dispense to eligible patients. Participating entities must comply with requirements in the 340B law related to eligibility, among other things. We looked at how the Department of Health and Human Services uses audits and other efforts to assess compliance. HHS audits have found more...", "title": "Drug Pricing Program: HHS Uses Multiple Mechanisms to Help Ensure Compliance with 340B Requirements", "topics": ["Regulatory noncompliance", "Drug pricing", "Medicaid", "Patient care", "Prescription drugs", "Compliance oversight", "Laws and regulations", "Pharmacy", "Audits", "Program integrity", "Health Care", "Program evaluation", "Managed health care", "Health care", "Drugs", "Drug prices", "Hospitals", "Policies and procedures"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-21-107", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-21-107-highlights.pdf"}, {"title": "Full Report (36 pages)", "url": "https://www.gao.gov/assets/gao-21-107.pdf"}, {"title": "Accessible PDF (42 pages)", "url": "https://www.gao.gov/assets/720/711409.pdf"}]}